TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18334081

Group type: EXPERIMENTAL
Intervention: NSAID use postoperatively
Number of subjects: 555
Study: 16177617

Group type: EXPERIMENTAL
Intervention: One set fast (approximately 140 degrees.s(‐1))
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Three sets fast
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: One set slow (approximately 50 degrees.s(‐1))
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Three sets slow
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Fast training
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Three sets or fast speeds
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 115
Study: 12947070

Group type: EXPERIMENTAL
Intervention: Clodronate 1,500 mg IV every 3 weeks + mitoxantrone 12 mg/m2 IV every 3 weeks + prednisone 5 mg orally bid
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo + mitoxantrone 12 mg/m2 IV every 3 weeks + prednisone 5 mg orally bid
Number of subjects: 209
Study: 10493337

Group type: EXPERIMENTAL
Intervention: Conventional inactivated influenza A vaccine
Number of subjects: 547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study: 8614525

Group type: EXPERIMENTAL
Intervention: 311C90 1 mg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 311C90 5 mg
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 311C90 25 mg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 1533289

Group type: EXPERIMENTAL
Intervention: Intravenous m-chlorophenylpiperazine (MCPP) 0.06 mg/kg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intravenous m-chlorophenylpiperazine (MCPP) 0.08 mg/kg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 3919556

Group type: EXPERIMENTAL
Intervention: 200 mg of bepridil hydrochloride
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: 300 mg of bepridil hydrochloride
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: 400 mg of bepridil hydrochloride
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study: 30720354

Group type: EXPERIMENTAL
Intervention: gshFBT
Number of subjects: 100
Study: 29982509

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate/emtricitabine
Number of subjects: 805

Group type: COMPARATOR
Intervention: Raltegravir
Number of subjects: 805
Study: 26827971

Group type: EXPERIMENTAL
Intervention: Removable retainers containing silver nanoparticles (about 40 nm in size and 500 ppm in concentration)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional removable retainers
Number of subjects: 66
Study: 25052821

Group type: EXPERIMENTAL
Intervention: Controlled reoxygenation CPB
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard oxygen levels CPB
Number of subjects: 79
Study: 22743160

Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy/Cognitive Behavioral Therapy (MET/CBT)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: MET/CBT+Contingency Management (CM)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Drug Counseling (DC)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: DC+CM
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 112

Group type: COMPARATOR
Intervention: All treatment types
Number of subjects: 112
Study: 20693799

Group type: EXPERIMENTAL
Intervention: Intravenous sotalol (75 mg over 2.5 h)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Oral sotalol (80 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: QTc = 0.0342 (sotalol concentration) + 398
Number of subjects: 15
Study: 18658112

Group type: EXPERIMENTAL
Intervention: Rhinovirus inoculation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Viperin knockdown with short interfering RNA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naturally acquired rhinovirus infections
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultured human epithelial cells infected with intact rhinovirus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultured human epithelial cells infected with replication-deficient rhinovirus
Number of subjects: 0
Study: 16151353

Group type: EXPERIMENTAL
Intervention: Prednisone (0.35 mg/kg daily for 18 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Diphenidol (25 mg/d) plus acetazolamide (250 mg/48 h)
Number of subjects: 16
Study: 12486431

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 853
Study: 10695780

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin 480 mg over 5 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin 640 mg over 7 days
Number of subjects: 40
Study: 7827868

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody (MAb) and complement treatment
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Purged marrow grafts
Number of subjects: 56
Study: 3163879

Group type: EXPERIMENTAL
Intervention: 50 mg Zn/d
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 75 mg Zn/d
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 31860170

Group type: EXPERIMENTAL
Intervention: Risk model based on identified risk factors (age, LDL, smoking, BMI, diabetes, OSAS, aspartate aminotransferase)
Number of subjects: 5561
Study: 29622143

Group type: EXPERIMENTAL
Intervention: Absorb BVS
Number of subjects: 150

Group type: COMPARATOR
Intervention: CoCr-EES
Number of subjects: 150
Study: 28096109

Group type: EXPERIMENTAL
Intervention: Presence of financial ties of principal investigators
Number of subjects: 195
Study: 24553479

Group type: EXPERIMENTAL
Intervention: Posterior pericardial window technique (PW)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Control (traditional technique)
Number of subjects: 458
Study: 23180503

Group type: EXPERIMENTAL
Intervention: Protocolized sedation plus daily sedation interruption (n = 214)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Protocolized sedation (control) (n = 209)
Number of subjects: 430
Study: 20683334

Group type: EXPERIMENTAL
Intervention: Sugammadex 2.0 mg kg(‐1)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Neostigmine 50 microg kg(‐1) with glycopyrrolate 10 microg kg(‐1)
Number of subjects: 98
Study: 18454877

Group type: EXPERIMENTAL
Intervention: Motor control exercises
Number of subjects: 172

Group type: COMPARATOR
Intervention: Graded activity program
Number of subjects: 172
Study: 16180595

Group type: EXPERIMENTAL
Intervention: Daily stretch positioning for wrist and finger flexors and shoulder adductors and internal rotators, two 30-min stretches per day for up to 12 weeks post stroke.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 25
Study: 12796526

Group type: EXPERIMENTAL
Intervention: Antipsychotic therapy
Number of subjects: 59
Study: 10234717

Group type: EXPERIMENTAL
Intervention: Atrioventricular delay of 200 ms
Number of subjects: 15

Group type: COMPARATOR
Intervention: Atrioventricular delay of 100 ms
Number of subjects: 15
Study: 8609746

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g single preoperative dose
Number of subjects: 2195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2195
Study: 1460707

Group type: EXPERIMENTAL
Intervention: 6 mm polytetrafluoroethylene (PTFE)
Number of subjects: 96

Group type: COMPARATOR
Intervention: 6 mm human umbilical vein (HUV)
Number of subjects: 96
Study: 6704274

Group type: EXPERIMENTAL
Intervention: Halothane (0.5‐1.5%)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fentanyl (mean 17 micrograms kg‐1)
Number of subjects: 20
Study: 31682747

Group type: EXPERIMENTAL
Intervention: First Breath program (new version)
Number of subjects: 88
Study: 30651946

Group type: EXPERIMENTAL
Intervention: Kinesiology taping
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo taping
Number of subjects: 19
Study: 25138195

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control
Number of subjects: 109
Study: 25250613

Group type: EXPERIMENTAL
Intervention: Sitafloxacin 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sitafloxacin 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sitafloxacin 200 mg
Number of subjects: 12
Study: 22920446

Group type: EXPERIMENTAL
Intervention: Electronically enabled discharge reconciliation and communication
Number of subjects: 3714

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3714
Study: 19935818

Group type: EXPERIMENTAL
Intervention: HIFV (nonrestrictive messages to increase fruit and vegetable intake)
Number of subjects: 68

Group type: COMPARATOR
Intervention: LOFAT (restrictive messages to limit high-fat foods)
Number of subjects: 68
Study: 17548731

Group type: EXPERIMENTAL
Intervention: Intravenous cooling with 4 degrees C normal saline (500 to 2000 mL)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Standard care without cooling
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: In-field cooling
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: In-field cooling in ventricular fibrillation patients
Number of subjects: 125
Study: 15562142

Group type: EXPERIMENTAL
Intervention: Aerosolized tobramycin (300 mg twice daily for 6 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11914208

Group type: EXPERIMENTAL
Intervention: PCIOL corneas stored in organ culture for 7 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Phakic controls stored in organ culture for 7 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: PCIOL corneas stored in organ culture for up to 2 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Phakic controls stored in organ culture for up to 2 weeks
Number of subjects: 27
Study: 9539304

Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP) 10 microg i.v.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ovine corticotropin-releasing hormone (oCRH) 1 microg/kg body weight
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low-dose ACTH 5 microg i.v.
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 7624918

Group type: EXPERIMENTAL
Intervention: New assay for measuring AChE activity
Number of subjects: 0
Study: 1776334

Group type: EXPERIMENTAL
Intervention: molsidomine (4 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: isosorbide‐5‐mononitrate (ISMN, 20 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 6295133

Group type: EXPERIMENTAL
Intervention: Initial surgery with adequate exploration of the opposite kidney
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nephroblastomatosis histologically
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Multicentric origin of tumors
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Overall survival free of disease
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Attention to surgical and histologic details during initial procedures
Number of subjects: 18
Study: 30942510

Group type: EXPERIMENTAL
Intervention: 15 mg of saffron (two pills per day) for 3 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo capsules (two pills per day) for 3 months
Number of subjects: 64
Study: 28287797

Group type: EXPERIMENTAL
Intervention: RELATE with CoupleCARE (RCC)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: RELATE online assessment with feedback and relationship goal setting (RELATE)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Book reading control condition (control)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Relationship education (RE)
Number of subjects: 182
Study: 27412550

Group type: EXPERIMENTAL
Intervention: Motivational interviewing combined with peer participation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional management
Number of subjects: 100
Study: 25222894

Group type: EXPERIMENTAL
Intervention: Universal decolonization
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Screening and isolation
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Targeted decolonization
Number of subjects: 1000
Study: 22624776

Group type: EXPERIMENTAL
Intervention: KT intervention (three interactive educational sessions, action planning, audit and feedback reports, internal champions, reminders/point-of-care tools)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: KT intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no intervention, received educational materials as part of the Ontario Osteoporosis Strategy)
Number of subjects: 40
Study: 20226444

Group type: EXPERIMENTAL
Intervention: Metformin plus leuprolide acetate (LA) placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (LA)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 17565560

Group type: EXPERIMENTAL
Intervention: Motivational Intervention (MI)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Feedback Only (FO)
Number of subjects: 198
Study: 16236177

Group type: EXPERIMENTAL
Intervention: Tigecycline (100 mg initial dose, then 50 mg every 12 hours for 5 to 14 days)
Number of subjects: 825

Group type: COMPARATOR
Intervention: Imipenem/cilastatin (500/500 mg every 6 hours or adjusted for renal dysfunction for 5 to 14 days)
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 825

Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 825
Study: 11940029

Group type: EXPERIMENTAL
Intervention: Botulinum neurotoxin Type A (BoNTA) intramuscular injections to triceps surae (800 U Dysport) and functional electrical stimulation (FES) of the common peroneal nerve with physiotherapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Physiotherapy only (Control)
Number of subjects: 21
Study: 9535593

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (40 min of bench stepping; 15 steps x min[‐1])
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no prior exercise)
Number of subjects: 10
Study: 8588792

Group type: EXPERIMENTAL
Intervention: dimenhydrinate (100 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 2228399

Group type: EXPERIMENTAL
Intervention: 60 mg dl-fenfluramine/meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo/meal
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 60 mg dl-fenfluramine/no meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo/no meal
Number of subjects: 16
Study: 338088

Group type: EXPERIMENTAL
Intervention: Modified Makari skin test
Number of subjects: 118
Study: 31324663

Group type: EXPERIMENTAL
Intervention: Eligible patients for clinical trials
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Invited patients
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Included patients
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Noninvitation associated with older age
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Overall eligibility and participation rates
Number of subjects: 577
Study: 27603578

Group type: EXPERIMENTAL
Intervention: Whey protein hydrolysate (WPH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Maltodextrin (CHO)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lengthening contractions
Number of subjects: 20

Group type: COMPARATOR
Intervention: Shortening contractions
Number of subjects: 20
Study: 25707693

Group type: EXPERIMENTAL
Intervention: 3-antigen Staphylococcus aureus vaccine (SA3Ag)
Number of subjects: 408
Study: 23949071

Group type: EXPERIMENTAL
Intervention: Repeated Passive Movement (RPM) exercise
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Repeated Active Movement (RAM) exercise
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 45
Study: 22533801

Group type: EXPERIMENTAL
Intervention: 40 weeks of reading and language intervention
Number of subjects: 57

Group type: COMPARATOR
Intervention: Waiting control (20 weeks of intervention after a delay)
Number of subjects: 57
Study: 19436218

Group type: EXPERIMENTAL
Intervention: HIV risk reduction intervention
Number of subjects: 48585
Study: 17451692

Group type: EXPERIMENTAL
Intervention: ACTH stimulation test
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (nonobese PCOS patients without insulin resistance)
Number of subjects: 20
Study: 15075548

Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E HIV vaccine trial participation
Number of subjects: 2545
Study: 11158948

Group type: EXPERIMENTAL
Intervention: Acute ascorbic acid treatment (2 g po)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Chronic ascorbic acid treatment (500 mg/day for 1 month)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 39
Study: 9563860

Group type: EXPERIMENTAL
Intervention: Low-pressure tourniquet system
Number of subjects: 26

Group type: COMPARATOR
Intervention: High-pressure tourniquet system
Number of subjects: 26
Study: 7951197

Group type: EXPERIMENTAL
Intervention: Immediate sleep group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal sleep group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal waking group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sleep deprivation group
Number of subjects: 0
Study: 3606869

Group type: EXPERIMENTAL
Intervention: Mammographic appearance of microcalcifications
Number of subjects: 92
Study: 29512838

Group type: EXPERIMENTAL
Intervention: Stabilisation splint treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Counselling and masticatory muscle exercises (Control)
Number of subjects: 80
Study: 27590017

Group type: EXPERIMENTAL
Intervention: 1 mg/kg PPS
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: 2 mg/kg PPS
Number of subjects: 4
Study: 23804582

Group type: EXPERIMENTAL
Intervention: Lifestyle change with metformin
Number of subjects: 706

Group type: COMPARATOR
Intervention: Lifestyle change with placebo
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Lifestyle change without metformin
Number of subjects: 706
Study: 22320846

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle rehabilitation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dapoxetine 30 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dapoxetine 60 mg
Number of subjects: 40
Study: 20827195

Group type: EXPERIMENTAL
Intervention: High cut-off haemodialysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib-based chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma exchange
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel chemotherapy agents
Number of subjects: 0
Study: 18983759

Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 0.6 g + folic acid 500 microg/day
Number of subjects: 166

Group type: COMPARATOR
Intervention: Folic acid 500 microg/day alone
Number of subjects: 166
Study: 16025785

Group type: EXPERIMENTAL
Intervention: Intensive acupuncture treatment (10 sessions over 3-4 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham acupuncture treatment (control group)
Number of subjects: 24
Study: 11817926

Group type: EXPERIMENTAL
Intervention: 14-week dietary/physical activity intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: General health intervention
Number of subjects: 0
Study: 10027375

Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior fundoplication
Number of subjects: 107

Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 107
Study: 8964646

Group type: EXPERIMENTAL
Intervention: LDL-apheresis
Number of subjects: 47

Group type: COMPARATOR
Intervention: Diet and lipid-lowering drugs
Number of subjects: 47
Study: 2178128

Group type: EXPERIMENTAL
Intervention: Ditiocarb
Number of subjects: 389

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study: 6113797

Group type: EXPERIMENTAL
Intervention: Midazolam (15 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Meprobamate (250 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 31808635

Group type: EXPERIMENTAL
Intervention: Canephron N
Number of subjects: 51

Group type: COMPARATOR
Intervention: Cystone
Number of subjects: 51
Study: 28906595

Group type: EXPERIMENTAL
Intervention: Occipital donor sites
Number of subjects: 108

Group type: COMPARATOR
Intervention: Thigh donor sites
Number of subjects: 108
Study: 25918759

Group type: EXPERIMENTAL
Intervention: Ortho/EMD/FDBA (OEF)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Ortho/EMD/DFDBA (OED)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Ortho/EMD alone (OE)
Number of subjects: 74
Study: 23769121

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control plus HBO therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: I/R plus HBO therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: COMPARATOR
Intervention: I/R group
Number of subjects: 0
Study: 21067882

Group type: EXPERIMENTAL
Intervention: Resection without radiotherapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Resection with external beam radiotherapy (RadRx)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Extracorporeal irradiation and re‐implantation (ECRRI) without radiotherapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Extracorporeal irradiation and re‐implantation (ECRRI) with radiotherapy (RadRx)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 19403877

Group type: EXPERIMENTAL
Intervention: 0.1 mg rhTSH
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.1 mg rhTSH/24-h interval
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 15476903

Group type: EXPERIMENTAL
Intervention: ProSorb diclofenac K 25 mg
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: ProSorb diclofenac K 50 mg
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: ProSorb diclofenac K 100 mg
Number of subjects: 265

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265
Study: 11681767

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (7 mg/24 hours)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 70
Study: 9603132

Group type: EXPERIMENTAL
Intervention: Topical soft tissue lubricant
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7996958

Group type: EXPERIMENTAL
Intervention: Endoscopic stenting
Number of subjects: 201

Group type: COMPARATOR
Intervention: Surgical biliary bypass
Number of subjects: 201